Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
894.33
826.13
854.13
836.74
885.97
815.78
1,323.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
894.33
826.13
854.13
836.74
885.97
815.78
1,323.13
Raw Material Cost
564.10
522.99
541.63
508.35
532.88
509.28
936.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.90
8.16
7.94
8.85
9.18
9.18
9.50
Selling and Distribution Expenses
155.23
139.47
184.24
174.27
173.55
151.75
214.64
Other Expenses
4.46
2.77
7.88
3.49
3.77
2.95
4.46
Total Expenditure (Excl Depreciation)
771.86
698.28
812.61
726.36
753.28
699.75
1,205.69
Operating Profit (PBDIT) excl Other Income
122.5
127.8
41.5
110.39999999999999
132.7
116
117.4
Other Income
4.57
11.11
-26.47
29.09
39.71
3.67
19.69
Operating Profit (PBDIT)
171.55
185.26
54.17
189.12
220.30
176.14
163.13
Interest
7.90
8.16
7.94
8.85
9.18
9.18
9.50
Exceptional Items
5.69
4.39
31.35
1.20
17.95
25.33
-34.19
Gross Profit (PBDT)
330.23
303.14
312.50
328.39
353.09
306.50
386.16
Depreciation
54.43
54.43
55.01
55.01
56.06
56.06
55.81
Profit Before Tax
114.91
127.06
22.57
126.46
173.01
136.22
63.63
Tax
8.02
11.05
-13.50
10.27
24.12
15.33
0.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
96.33
107.78
38.21
105.78
140.54
115.98
55.99
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
96.33
107.78
38.21
105.78
140.54
115.98
55.99
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
8.18
9.63
5.47
12.94
11.42
4.12
9.67
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
104.51
117.41
43.68
118.73
151.96
120.10
65.65
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,706.18
4,810.86
4,703.08
4,673.16
4,561.89
4,565.98
4,469.99
Earnings per share (EPS)
0.21
0.24
0.08
0.23
0.31
0.25
0.12
Diluted Earnings per share
0.21
0.24
0.08
0.23
0.31
0.25
0.12
Operating Profit Margin (Excl OI)
12.58%
14.49%
3.0%
12.55%
14.06%
14.27%
6.62%
Gross Profit Margin
18.94%
21.97%
9.08%
21.69%
25.86%
23.57%
9.03%
PAT Margin
10.77%
13.05%
4.47%
12.64%
15.86%
14.22%
4.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 8.26% vs -3.28% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -10.99% vs 168.65% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -4.13% vs 116.13% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -3.66% vs 3.80% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Tianjin Ringpu Bio-technology Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
894.33
0
894.33
Other Operating Income
0.00
0.00
0.00
Total Operating income
894.33
0
894.33
Raw Material Cost
564.10
0
564.10
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.90
0
7.90
Selling and Distribution Expenses
155.23
0
155.23
Other Expenses
4.46
0.00
4.46
Total Expenditure (Excl Depreciation)
771.86
0
771.86
Operating Profit (PBDIT) excl Other Income
122.48
0.00
122.48
Other Income
4.57
0
4.57
Operating Profit (PBDIT)
171.55
0
171.55
Interest
7.90
0
7.90
Exceptional Items
5.69
0
5.69
Gross Profit (PBDT)
330.23
0
330.23
Depreciation
54.43
0
54.43
Profit Before Tax
114.91
0
114.91
Tax
8.02
0
8.02
Provisions and contingencies
0
0
0.00
Profit After Tax
96.33
0
96.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
96.33
0
96.33
Share in Profit of Associates
0
0
0.00
Minority Interest
8.18
0
8.18
Other related items
0.00
0.00
0.00
Consolidated Net Profit
104.51
0
104.51
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,706.18
0
4,706.18
Earnings per share (EPS)
0.21
0
0.21
Diluted Earnings per share
0.21
0
0.21
Operating Profit Margin (Excl OI)
12.58%
0%
0.00
12.58%
Gross Profit Margin
18.94%
0%
0.00
18.94%
PAT Margin
10.77%
0%
0.00
10.77%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 89.43 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 8.26% vs -3.28% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.94% vs 56.59% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.45 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -10.99% vs 168.65% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -31.25% vs 104.58% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.70 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -4.13% vs 116.13% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -7.53% vs 52.66% in Jun 2025
Quarterly - Interest
Interest 0.79 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -3.66% vs 3.80% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -14.13% vs 31.43% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.58%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
